Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules targeting neurological and inflammatory disorders. Its structure supports the formation of selective receptor ligands due to the presence of a constrained azetidine ring and a piperidine scaffold, both favorable for enhancing binding affinity and metabolic stability. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates. Also utilized in the preparation of protease inhibitors and CNS-active agents where controlled lipophilicity and improved blood-brain barrier penetration are required.